OBJECTIVES: To examine the role of vascular endothelial cadherin (VE-cadherin) in cellular processes underlying angiogenesis and the effects of VE-cadherin inhibition on retinal angiogenesis. METHODS: Retinal neovascularization was induced in newborn mice by exposure to 75% oxygen (postnatal days 7-12) followed by room air and quantitated from histological sections. Mice received daily intraperitoneal injections of either a VE-cadherin antagonist or a control peptide from postnatal days 12 to 17. In vitro cell migration, proliferation, and tubule formation were examined in the presence of the VE-cadherin antagonist. The effect of antagonist treatment on the integrity of established cell junctions was examined by fluorescein isothiocyanate-dextran monolayer permeability and VE-cadherin immunocytochemistry. RESULTS: Treatment with the VE-cadherin antagonist significantly reduced retinal angiogenesis. Inhibition of VE-cadherin function suppressed tubule formation in endothelial cells. The antagonist treatment also decreased cell migration and proliferation. The antagonist treatment did not affect the integrity of existing cell junctions. Immunostaining for VE-cadherin and rates of monolayer permeability were comparable to those in untreated controls. CONCLUSION: Our study points to a pivotal role played by VE-cadherin in the angiogenic process. CLINICAL RELEVANCE: Inhibition of VE-cadherin might be an effective strategy for pharmacological inhibition in proliferative retinopathies.
OBJECTIVES: To examine the role of vascular endothelial cadherin (VE-cadherin) in cellular processes underlying angiogenesis and the effects of VE-cadherin inhibition on retinal angiogenesis. METHODS: Retinal neovascularization was induced in newborn mice by exposure to 75% oxygen (postnatal days 7-12) followed by room air and quantitated from histological sections. Mice received daily intraperitoneal injections of either a VE-cadherin antagonist or a control peptide from postnatal days 12 to 17. In vitro cell migration, proliferation, and tubule formation were examined in the presence of the VE-cadherin antagonist. The effect of antagonist treatment on the integrity of established cell junctions was examined by fluorescein isothiocyanate-dextran monolayer permeability and VE-cadherin immunocytochemistry. RESULTS: Treatment with the VE-cadherin antagonist significantly reduced retinal angiogenesis. Inhibition of VE-cadherin function suppressed tubule formation in endothelial cells. The antagonist treatment also decreased cell migration and proliferation. The antagonist treatment did not affect the integrity of existing cell junctions. Immunostaining for VE-cadherin and rates of monolayer permeability were comparable to those in untreated controls. CONCLUSION: Our study points to a pivotal role played by VE-cadherin in the angiogenic process. CLINICAL RELEVANCE: Inhibition of VE-cadherin might be an effective strategy for pharmacological inhibition in proliferative retinopathies.
Authors: L Caveda; I Martin-Padura; P Navarro; F Breviario; M Corada; D Gulino; M G Lampugnani; E Dejana Journal: J Clin Invest Date: 1996-08-15 Impact factor: 14.808
Authors: Fang Liao; Jacqueline F Doody; Jay Overholser; Bridget Finnerty; Rajiv Bassi; Yan Wu; Elisabetta Dejana; Paul Kussie; Peter Bohlen; Daniel J Hicklin Journal: Cancer Res Date: 2002-05-01 Impact factor: 12.701
Authors: P Carmeliet; M G Lampugnani; L Moons; F Breviario; V Compernolle; F Bono; G Balconi; R Spagnuolo; B Oosthuyse; M Dewerchin; A Zanetti; A Angellilo; V Mattot; D Nuyens; E Lutgens; F Clotman; M C de Ruiter; A Gittenberger-de Groot; R Poelmann; F Lupu; J M Herbert; D Collen; E Dejana Journal: Cell Date: 1999-07-23 Impact factor: 41.582
Authors: Maria B Grant; W Stratford May; Sergio Caballero; Gary A J Brown; Steven M Guthrie; Robert N Mames; Barry J Byrne; Timothy Vaught; Polyxenie E Spoerri; Ammon B Peck; Edward W Scott Journal: Nat Med Date: 2002-06 Impact factor: 53.440
Authors: S Gory-Fauré; M H Prandini; H Pointu; V Roullot; I Pignot-Paintrand; M Vernet; P Huber Journal: Development Date: 1999-05 Impact factor: 6.868
Authors: Jing Chen; Andreas Stahl; Nathan M Krah; Molly R Seaward; Roberta J Dennison; Przemyslaw Sapieha; Jing Hua; Colman J Hatton; Aimee M Juan; Christopher M Aderman; Keirnan L Willett; Karen I Guerin; Akiko Mammoto; Matthew Campbell; Lois E H Smith Journal: Circulation Date: 2011-10-03 Impact factor: 29.690